Acetaminophen Tablet, Extended Release
Product Images NDC 62207-188

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Acetaminophen (NDC 62207-188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetaminophen 650mg Er

Label for Acetaminophen Extended Release Tablets USP, 650 mg. The label lists batch number, manufacturing date, expiry date, NDC number 62207-183-34, manufacturing license number, packaging quantity of 5 x 3000 tablets, and product weight details. It includes storage instructions to keep between 20-25 °C and notes for repacking only. The label also indicates the country of origin as India and displays barcodes.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label1)

The packaging label for Acetaminophen Extended-release tablets USP, 650 mg, manufactured by Granules India Limited. It highlights the product as a pain reliever and fever reducer providing muscle aches and pain relief for up to 8 hours. The label includes the Drug Facts panel with active ingredient information, warnings, directions, and inactive ingredients. The package contains 10 capsule-shaped bi-layer tablets and indicates the product is made in India and distributed by Granules USA, Inc.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label2)

ACETAMINOPHEN Extended-release tablets USP, 650 mg, oral tablet, packaged as 10 caplets. The label indicates the product is a pain reliever and fever reducer for the temporary relief of minor arthritis pain. Labeler is Granules India Limited. The packaging includes Drug Facts detailing active ingredients, uses, warnings, directions, and inactive ingredients. Made in India and distributed by Granules USA, Inc.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label3)

Drug Facts panel for Acetaminophen Extended-release tablets USP 650 mg shows the active ingredient and purpose as pain reliever/fever reducer. It lists uses such as relief of minor aches and pains including muscular aches, backache, arthritis pain, toothache, menstrual cramps, headache, and common cold, along with fever reduction. Contains warnings about liver damage risk if more than 6 caplets are taken. Also includes manufacturing and distribution details and cautions not to use with other acetaminophen-containing medicines.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label4)

Label for Acetaminophen Extended-release tablets USP, 650 mg by Granules India Limited. The label indicates 10 caplets, each containing 650 mg of acetaminophen used as a pain reliever and fever reducer. It includes drug facts, usage details, liver warning, and distribution information. The product is made in India and distributed by Granules USA, Inc.*

FDA Label Image

Acetaminophen 650mg

Label for Acetaminophen Extended Release Tablets USP, 650 mg. The label states each tablet contains 650 mg acetaminophen, with 3000 units per batch. Includes batch number, manufacturing and expiration dates (placeholders), NDC number 62207-183-87, manufacturing license number, storage instructions at 20-25°C (68-77°F), and caution for repacking only. The country of origin is India.*

FDA Label Image

Acetaminophen Er 650mg Bulk Jpg

Label for Acetaminophen Extended Release Tablets USP 650 mg shows it contains acetaminophen 650 mg per tablet. The label includes batch number, manufacturing and expiration dates as placeholders, NDC number 62207-183-97, and license number. It specifies storage conditions, pack size 30 kg, and country of origin India. The label is signed digitally by Sujani Pillapalem.*

FDA Label Image

Acetaminophen Label1 Jpg

Drug Facts panels for Acetaminophen Extended-release Tablets USP 650 mg by Granules India Limited. The first panel highlights active ingredient, uses (pain reliever/fever reducer), warnings including liver warnings, allergy alerts, and usage precautions. The second panel continues with overdose warnings, directions for adults and children, other information, inactive ingredients, and contact information for questions. The label includes barcode, manufacturing details, lot and expiration placeholders, and distributor address.*

FDA Label Image

Acetaminophen Label2 Jpg

Drug Facts label for Acetaminophen extended-release tablets USP 650 mg by Granules India Limited. The label details active ingredient, purpose, uses, warnings including liver warnings and allergy information, directions for use, overdose warnings, inactive ingredients, storage conditions, and contact information for questions. The label notes the product is not for retail sale and contains 1000 capsule-shaped bi-layer tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.